Bio Medica Laboratories Limited IPO Details
Factual IPO information from public filings. Not investment advice.
Issue Details
- Price Band
- ₹132 – ₹139
- Lot Size
- 1,000 shares
- Min. Investment
- ₹1,39,000
- Total Issue Size
- ₹52.43 Cr
- 37,72,000 shares
- Fresh Issue
- ₹47.19 Cr
- 33,95,000 shares
- Offer for Sale
- ₹5.24 Cr
- 3,77,000 shares
- Face Value
- ₹10 per share
- Issue Type
- Book-built IPO
- Listing At
- NSE SME
- Shares Pre-Issue
- 91,80,001
- Shares Post-Issue
- 1,25,75,001
Lot Size & Investment
1 lot = 1,000 shares
Retail (min)
2 lots · 2,000 shares
Retail (max)
2 lots · 2,000 shares
S-HNI (min)
3 lots · 3,000 shares
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 2 | 2,000 | ₹2,78,000 |
| Small HNI (S-HNI) | 3 | 3,000 | ₹4,17,000 |
| Big HNI (B-HNI) | 8 | 8,000 | ₹11,12,000 |
Financial Performance
Restated figures in ₹ crore, unless stated otherwise
| Period | Nov-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Assets | 65.17 | 39.12 | 19.53 | 17.57 |
| Total Income | 28.63 | 38.33 | 15.34 | 16.25 |
| Profit After Tax | 8.66 | 9.79 | 2.5 | 0.33 |
| EBITDA | 13.45 | 15.21 | 5.63 | 1.7 |
| Net Worth | 17.12 | 14.73 | 4.94 | 2.44 |
| Reserves & Surplus | 7.94 | 5.55 | 4.84 | 2.34 |
| Total Borrowing | 38.17 | 15.01 | 10.49 | 9.61 |
Key Performance Indicators
| Period | Nov-25 | Mar-25 |
|---|---|---|
| ROE (%) | 54.41 | 99.59 |
| ROCE (%) | 23.22 | 48.2 |
| EPS (₹) | — | 10.67 |
| P/E (pre-issue) | — | 13.03 |
| P/E (post-issue) | — | 13.45 |
About Bio Medica Laboratories Limited
Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare. Product portfolio: Liquid Injectables: 58 products are offered under this category Dry powder injectables: 15 products under this category It offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications. The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh. It has two manufacturing facilities in Indore, Madhya Pradesh. Competitive Strengths Multi-product capability and diversified product portfolio Experienced promoters, management and employees. Quality assurance Established client relationship
Company Information
- Book running lead managers
- Narnolia Financial Services Ltd.
- Registered office
- Plot No.11B-11C, Sector-E, Sanwer Road, Industrial Area, Industrial Estate, Indore, Madhya Pradesh, 452015
- Market maker
- Prabhat Financial Services Ltd.